Footwear Minimalism Study

NCT ID: NCT01334346

Last Updated: 2013-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

91 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The following study proposes to investigate the injury risk associated with the use of a new category of running footwear: the minimalist shoe. A group of experienced adult male and female runners with neutral foot types will take part in this study. All participants will be randomized to receive one of three different shoes: a full minimalist shoe (Vibram 5-Fingers), a partial minimalist shoe (Nike Free 3.0) and a conventional neutral supportive running shoe (Nike Pegasus), while training for a 10k event over a 14-week period. Outcomes to be investigated are pain, footwear perception, and number of injury events.

The hypothesizes is that participants using the minimalist footwear during their running program will experience a reduction in running related pain. A greater degree of footwear minimalism will result in a greater reduction in pain (compared to the partial minimalist shoe, Nike Free).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Runners

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Running Footwear Injury incidence injury risk pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neutral Shoe

Conventional, non-minimalist, footwear.

Group Type ACTIVE_COMPARATOR

Nike Pegasus

Intervention Type OTHER

Conventional neutral supportive running footwear. Non minimalist.

Partial minimalist shoe

Group Type EXPERIMENTAL

Nike Free 3.0

Intervention Type OTHER

Partial minimalist shoe with partially elevated heel, but with increased mid-sole flexibility.

Full minimalist

Group Type EXPERIMENTAL

Vibram Five Fingers Shoe

Intervention Type OTHER

Full minimalist shoe. Virtually no mid-sole, therefore no heel elevation or forefoot rockering. A proxy for a barefoot running condition.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nike Pegasus

Conventional neutral supportive running footwear. Non minimalist.

Intervention Type OTHER

Nike Free 3.0

Partial minimalist shoe with partially elevated heel, but with increased mid-sole flexibility.

Intervention Type OTHER

Vibram Five Fingers Shoe

Full minimalist shoe. Virtually no mid-sole, therefore no heel elevation or forefoot rockering. A proxy for a barefoot running condition.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minimum of 5 years experience running
* Have been running on a regular basis (minimum once per week) over the past 6 months
* Able to run for 60 minutes continuously
* Can tolerate 20-40km per week in training
* Neutral foot posture according to the Foot Posture Index.

Exclusion Criteria

* Have not experienced a running related injury requiring a stoppage of 2-weeks or more in the past 6 months
* History of surgery to their plantar fascia or Achilles tendon
* Have already been running in a minimalist shoe
* Have a diagnosis of osteoarthritis - or other degenerative musculoskeletal disorder - affecting the lower extremity
* Are currently taking analgesic medication.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nike

INDUSTRY

Sponsor Role collaborator

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jack Taunton, MD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of British Columbia

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H11-00931

Identifier Type: -

Identifier Source: org_study_id